Development of L-689,065 - the prototype of a new class of potent 5-lipoxygenase inhibitors

This publication has 10 references indexed in Scilit:

• Formation of a novel thiopyranoindole ring system
  Tetrahedron Letters, 1992
• 5-Lipoxygenase: properties, pharmacology, and the quinolinyl(bridged)aryl class of inhibitors
  Journal of Medicinal Chemistry, 1992
• Pharmacology of MK-0591 (3-[1-(4-chlorobenzyl)-3-(t-butylthio)-5-(quinolin-2-yl-methoxy)-indol-2-yl]-2,2-dimethyl propanoic acid), a potent, orally active leukotriene biosynthesis inhibitor
  Canadian Journal of Physiology and Pharmacology, 1992
• Role of Leukotrienes in Exercise-induced Asthma: Inhibitory Effect of ICI 204219, a Potent Leukotriene D₄Receptor Antagonist
  American Review of Respiratory Disease, 1992
• 677 The therapeutic effects of MK-571, a potent and selective leukotriene (LT) D4 receptor antagonist, in patients with chronic asthma
  Journal of Allergy and Clinical Immunology, 1991
• The Effects of a 5-Lipoxygenase Inhibitor on Asthma Induced by Cold, Dry Air
  New England Journal of Medicine, 1990
• Identification and isolation of a membrane protein necessary for leukotriene production
  Nature, 1990
• L-663,536 (MK-886) (3-[1-(4-chlorobenzyl)-3-t-butyl-thio-5-isopropylindol-2-yl]-2,2-dimethylpropanoic acid), a novel, orally active leukotriene biosynthesis inhibitor
  Canadian Journal of Physiology and Pharmacology, 1989
• Inhibition of allergen-induced bronchoconstriction in hyperreactive rats as a model for testing 5-lipoxygenase inhibitors and leukotriene D4 receptor antagonists
  Inflammation Research, 1987
• Modulation of rat polymorphonuclear leukocyte 5-lipoxygenase activity by 5-HPETE and NADH-dependent flavin inhibition
  Biochemical and Biophysical Research Communications, 1986